The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAvantec Vascular

About this trial

The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.

Eligibility criteria

Qualifiers

Age ≥18 years

Candidate for atherectomy of the peripheral vasculature in the lower limbs

Life expectancy >1 year in the opinion of the investigator

Resting ankle brachial index (ABI) ≤0.90, or ≤0.75 after exercise. Subjects with non-compressible arteries shall have a toe brachial index (TBI) assessment.

Disqualifiers

Active infection in the target limb

History of an endovascular procedure or open vascular surgery on the target limb within the last 30 days

Planned surgical or interventional procedure within 30 days after the index procedure

Lesion in the contralateral limb requiring intervention during the index procedure or within next 30 days

Trial design

Treatments tested in this trial

  • Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)

Treatment groups

159 Participants
are divided into 1 treatment group

Sponsors and collaborators

Avantec Vascular

Lead sponsor

Bright Research Partners

Collaborator

Yale Cardiovascular Research Group

Collaborator